image description

Tag: Martin Kriegel

Gut Bacteria May Hold the Key to New Lupus Treatments

A groundbreaking study led by Martin Kriegel, MD, PhD, Chief of Rheumatology and Clinical Immunology at the University of Münster, Germany, has revealed that certain gut bacteria can escape the gut and stimulate harmful immune activity in lupus patients. The research, published in the prestigious journal Science Translational Medicine, sheds light on the mechanisms behind […] Read More

Researchers Discover How Gut Bacteria Can Trigger Autoimmunity

August 4, 2022 Immunologists have found that a certain gut bacteria escapes from the intestines to trigger inflammation that can lead to autoimmune diseases. A new study published in Nature provides an insight into how particular gut bacteria evolve over time through a phenomenon called ‘within-host evolution’. The new findings open the door for the […] Read More

LRA Celebrates Major Research Breakthroughs in 2019

January 7, 2020 2019 was a phenomenal, breakthrough year for lupus research on both the clinical development and basic science fronts. The Lupus Research Alliance (LRA) is incredibly proud that every new discovery leading to a brand new medicine for lupus had its origin in work funded by LRA years ago. The past 12 months delivered many […] Read More

Bacteria Could be to Blame for Autoimmune Attacks

March 12, 2018 Innovative novel research, co-funded by the Lupus Research Alliance, has produced a significant discovery about the role of bacteria and points to the potential for a vaccine or treatment that might prevent an autoimmune attack by suppressing specific bacteria. Led by Dr. Martin Kriegel at Yale University, the study was published today […] Read More